Methods and kits for predicting tumor responses to antibodies against epidermal growth factor receptor (EGFR) and uses thereof

摘要

Disclosed are pharmaceutical preparations for, and methods for determining, appropriate and effective treatment with therapeutic agents comprising a single species of anti-EGFR monoclonal antibody or therapeutic agents comprising a plurality of species of such antibodies, as well as kits useful for making such determinations.